Antimicrobial treatment of community-acquired pneumonia
- PMID: 15802167
- PMCID: PMC7119139
- DOI: 10.1016/j.ccm.2004.10.006
Antimicrobial treatment of community-acquired pneumonia
Abstract
Community-acquired pneumonia (CAP) is a clinical diagnosis that has a significant impact on health care management around the world. Early clinical suspicion and prompt empiric antimicrobial therapies are mandatory in patients with CAP. This article provides a review of recent studies and guidelines addressing antimicrobial therapy for hospitalized patients with CAP.
References
-
- Anonymous Pneumonia and influenza death rates–United States, 1979–1994. MMWR Morb Mortal Wkly Rep. 1995;44(28):535–537. - PubMed
-
- National Center for Health Statistics CDC . Advance report of final mortality statistics 1992. US Department of Health and Human Services, Public Health Service; Hyattsville (MD): 1994.
-
- Marston B.J., Plouffe J.F., File T.M., Jr Incidence of community-acquired pneumonia requiring hospitalization: results of a population-based active surveillance study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med. 1997;157(15):1709–1718. - PubMed
-
- Niederman M.S., Mandell L.A., Anzueto A. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163(7):1730–1754. - PubMed
-
- Anonymous ERS Task Force Report: guidelines for management of adult community-acquired lower respiratory tract infections. European Respiratory Society. Eur Respir J. 1998;11(4):986–991. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
